American Association for Cancer Research (AACR): AACR-Johnson & Johnson Lung Cancer Innovation Science Grants

Supports collaborative cancer research in areas that include digital therapeutics and smoking cessation biomarkers/behavioral phenotyping, to bolster our understanding of how lung cancer can be successfully intercepted. Proposed research should have direct application and relevance to lung cancer prevention and interception and be translational in nature and include a clinical component with an endpoint relevant to improving the detection or treatment of lung cancer.

Top of Form

A multi-institutional team, composed of Principal Investigators from at least two, but no more than three, different institutions is required for this program. In addition to the co-PIs, the Project Team should also include at least one young investigator.

Funding: $ 1,000,000 for 3 years.

AACR membership is required.

Overhead 10% - Please contact Research Authority if planning to submit.

https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=71